The culture of volunteerism is a fundamental part of the Novartis corporate ethos. Here’s a snapshot of our efforts over the years.

A conversation with Joachim Momm, head of a Novartis manufacturing site that will be helping to produce Pfizer-BioNTech vaccine doses.

Public health expert Richard Laing discusses how independent measurement of access programs can help ensure their success

The head of Public Affairs for the Novartis Malaria Initiative has a malaria story of her own to tell.

Among the many Syrians uprooted by armed conflict are thousands of people with chronic conditions – such as diabetes and heart disease - whose treatment was disrupted when they fled.

For over 60 years Novartis has been committed to helping people with cardiovascular disease and we remain steadfast in that commitment to this day.

Novartis researchers have discovered a compound that is showing promise against three parasites that cause three neglected diseases.

These stories offer a glimpse into the lives of people touched by a new era of medicine.

Florencia Segal’s experiences prepared her to lead the rapid design of a large COVID-19 clinical trial.

Novartis is taming nuclear power and putting it to use to treat advanced cancer.